Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CVS Health Corp (NYSE:CVS)

81.56
Delayed Data
As of Jan 20
 -1.64 / -1.97%
Today’s Change
69.30
Today|||52-Week Range
106.67
+3.36%
Year-to-Date
CVS Regular Dividend: CVS began trading ex-dividend on 01/20/17. A $0.50 dividend will be paid to shareholders of record as of 01/24/17.
CVS Health Corporation in 4 Charts
Jan 20 / MotleyFool.com - Paid Partner Content
3 Reasons CVS Health Corporation Stock Could Rise
Jan 18 / MotleyFool.com - Paid Partner Content
Bank of America, JPMorgan Chase and Other Stellar Banks: 'Mad Money' Lightning Round
Jan 19 / TheStreet.com - Paid Partner Content
7 Stocks With Strong Yields
Jan 17 / GuruFocus News - Paid Partner Content
EpiPen Competitor, Auvi-Q, Will Hit the Market in February
Jan 19 / TheStreet.com - Paid Partner Content
Better Buy: CVS Health Corporation vs. Kroger
Jan 17 / MotleyFool.com - Paid Partner Content
Target Slides 6% on Disappointing Holiday Sales
Jan 18 / Zacks.com - Paid Partner Content
Examining Volkswagen and Fiat Chrysler's Emissions Cheating Scandals
Jan 13 / Zacks.com - Paid Partner Content
Hills Bank & Trust Co Buys CVS Health Corp, Alliance Data Systems Corp, Twenty-First ...
Jan 18 / GuruFocus News - Paid Partner Content
Hate Checking Your Portfolio? Try These 3 Stocks
Jan 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close83.20
Today’s open83.29
Day’s range81.31 - 83.43
Volume8,004,129
Average volume (3 months)7,761,539
Market cap$87.0B
Dividend yield2.45%
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+16.72%
Earnings growth (this year)+12.55%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+9.99%
P/E ratio17.5
Price/Sales0.72
Price/Book2.41

Competitors

 Today’s
change
Today’s
% change
WBAWalgreen-1.77-2.12%
ESRXExpress Scripts Hold...-0.70-0.97%
RADRite Aid Corp-1.14-13.26%
DPLODiplomat Pharmacy In...+0.41+3.13%
Data as of 4:14pm ET, 01/20/2017

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$1.67
Annual revenue (last year)$153.3B
Annual profit (last year)$5.2B
Net profit margin3.39%

Profile

Sector
Retail Trade
Industry
Drugstore Chains
President, CEO &
Non-Independent Director
Larry J. Merlo
Chief Financial Officer &
Executive Vice President
David M. Denton
Corporate headquarters
Woonsocket, Rhode Island

Forecasts


Search for Jobs